Colorectal Cancer Therapeutics Market, By Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, and Others), By Drug Class (Immunotherapy, Chemotherapy, and Targeted Therapy), By Sales Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), By Top Selling Drugs (5-Flurorouracil, Capecitabine, Irinotecan, Oxaliplatin, and Trifluridine & Tipiracil) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI488522 | Publish Date: May 2024 | No. of Pages: 178

Colorectal Cancer Therapeutics Market Companies

  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
  • Hikma Pharmaceuticals Plc
  • Amneal Pharmaceuticals Inc
  • Amgen Inc
  • Bayer AG
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Biocon Ltd.

Recent News:

  • According to the research article from PubMed Central, in June 2023, colorectal cancer is one of the leading causes of cancer-associated deaths worldwide. However, during the last 20 years, targeted therapy development has completely changed the way CRC is treated. Numerous novel medications have been created that target the precise molecular biomarkers that these cancers display and make them detectable and actionable. The CRC death rate in the US has dropped dramatically by more than 50% as a result of this developing science called precision oncology.